SANTORO, Domenico
 Distribuzione geografica
Continente #
EU - Europa 8.805
NA - Nord America 8.373
AS - Asia 2.437
SA - Sud America 19
Continente sconosciuto - Info sul continente non disponibili 11
OC - Oceania 9
AF - Africa 3
Totale 19.657
Nazione #
US - Stati Uniti d'America 8.307
IT - Italia 2.664
IE - Irlanda 2.295
SE - Svezia 1.885
CN - Cina 1.212
SG - Singapore 910
DE - Germania 527
UA - Ucraina 459
FI - Finlandia 371
IN - India 205
GB - Regno Unito 152
PL - Polonia 109
FR - Francia 106
BE - Belgio 56
CA - Canada 55
CZ - Repubblica Ceca 33
VN - Vietnam 30
NL - Olanda 29
RU - Federazione Russa 23
RO - Romania 21
ID - Indonesia 20
AT - Austria 19
CH - Svizzera 10
EU - Europa 10
GR - Grecia 10
BR - Brasile 8
HK - Hong Kong 8
IL - Israele 8
ES - Italia 7
JP - Giappone 7
KR - Corea 7
MX - Messico 7
AU - Australia 6
IR - Iran 6
AL - Albania 5
BG - Bulgaria 5
CL - Cile 5
LV - Lettonia 4
AE - Emirati Arabi Uniti 3
CY - Cipro 3
EG - Egitto 3
NP - Nepal 3
PE - Perù 3
TR - Turchia 3
EC - Ecuador 2
LU - Lussemburgo 2
MD - Moldavia 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
TH - Thailandia 2
UZ - Uzbekistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BO - Bolivia 1
BS - Bahamas 1
BT - Bhutan 1
BY - Bielorussia 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
GT - Guatemala 1
HR - Croazia 1
IQ - Iraq 1
JO - Giordania 1
LT - Lituania 1
MY - Malesia 1
NC - Nuova Caledonia 1
PA - Panama 1
PK - Pakistan 1
PT - Portogallo 1
SA - Arabia Saudita 1
TJ - Tagikistan 1
TW - Taiwan 1
Totale 19.657
Città #
Dublin 2.292
Chandler 1.595
Jacksonville 1.097
Nyköping 963
Singapore 726
Beijing 564
Princeton 427
Medford 393
Ashburn 358
Cambridge 358
Dearborn 354
Des Moines 316
Messina 275
Ann Arbor 243
Boardman 187
Rome 165
Hyderabad 146
New York 137
San Mateo 120
Milan 118
Warsaw 104
Woodbridge 102
Jinan 97
Wilmington 96
Bremen 74
Houston 66
Shenyang 63
Nanjing 55
Brussels 53
Catania 50
Pune 50
Los Angeles 46
Ottawa 44
Hebei 41
Palermo 41
Seattle 40
Genova 38
Tianjin 36
Lancaster 34
Helsinki 33
Ningbo 32
Norwalk 32
Brno 31
Haikou 31
Munich 30
Turin 30
Zhengzhou 30
Bologna 29
Dong Ket 28
Taizhou 27
Napoli 26
Hangzhou 25
Naples 25
Florence 23
Nanchang 23
Guangzhou 21
Jakarta 19
Dallas 18
Fuzhou 17
Vienna 17
Frankfurt am Main 16
Padova 16
Focsani 15
Jiaxing 15
Tappahannock 15
Washington 15
Redmond 14
Torino 13
Taiyuan 12
Bari 11
Falls Church 11
Genoa 11
Lentini 10
Reggio Calabria 10
San Pietro Di Feletto 10
Auburn Hills 9
Cosenza 9
Fairfield 9
Hefei 9
Milazzo 9
Pescara 9
Redwood City 9
Salerno 9
Augusta 8
Changsha 8
Enna 8
Gallese 8
Hong Kong 8
Berlin 7
Bronte 7
Lappeenranta 7
Rende 7
Trecastagni 7
Verona 7
Vicenza 7
Carugate 6
Catanzaro 6
Giussano 6
Lanzhou 6
Misterbianco 6
Totale 12.896
Nome #
La sindrome MIA ( malnutrizione-infiammazione-aterosclerosi nel paziente uremico 1.375
Amiloidosi renale e fibrosi cistica: Ruolo della terapia con colchicina 499
Terapia nutrizionale nell'IRC in fase conservativa: suggerimenti di pratica clinica e di applicazione delle linee guida 313
Flavocoxid, a Natural Antioxidant, Protects Mouse Kidney from Cadmium-Induced Toxicity. 124
Metformin-related lactic acidosis: is it a myth or an underestimated reality? 109
Association of higher advanced oxidation protein  products (AOPPs) levels in patients with diabetic  and hypertensive nephropathy 93
Association of individual non-steroidal anti-inflammatory drugs and chronic kidney disease: a population-based case control study 91
Sclerostin levels in uremic patients: a link between bone and vascular disease 83
TGF-beta ed ADPKD. Studio immunoistochimico al CLSM 82
Comparative Effectiveness of Biosimilar, Reference Product and Other Erythropoiesis-Stimulating Agents (ESAs) Still Covered by Patent in Chronic Kidney Disease and Cancer Patients: An Italian Population-Based Study 82
Delayed graft function and chronic allograft nephropathy: Diagnostic and prognostic role of neutrophil gelatinase-associated lipocalin 81
Compliance ed emozioni in una popolazione di emodializzati. 80
Erectyle dysfunction in uremic dialysis patients : diagnostic evaluation in the sildenafil era 78
Stress ossidativo in una popolazione di ipertesi e nefropatici: utilità del dosaggio dell’AOPP 77
ACCUMULO DI TECNEZIO IN METASTASI POLMONARI DA CARCINOMA DIFFERENZIATO TIROIDEO (CDT): UNA RARA EVENIENZA 76
Hypernatraemia and low eGFR at hospitalization in COVID-19 patients: a deadly combination 76
Adaptation of the Mishel Uncertainty of Illness Scale (MUIS) for chronic patients in Italy 75
Association of parathyroid carcinoma and thyroid disorders: A clinical review 75
In search of potential predictors of erythropoiesis-stimulating agents (ESAs) hyporesponsiveness: A population-based study 74
History of L-carnitine: Implications for renal disease 73
Impotence in the 18th and 19th century: concepts of etiology and approaches to therapy. 73
Modulazione dei dosaggi di EPO in terapia carnitinica 73
Role of Paricalcitol in Modulating the Immune Response in Patients with Renal Disease 73
Pain in Renal Disease. 72
EFFECTIVENESS OF L-CARNITINE THERAPY IN UREMIC ANEMIA 71
Possible regulation of Extracellular Matrix Changes by Transforming Growth Factor-ß in ADPKD 70
[Management of hyperphosphatemia in patients with chronic kidney disease] 70
The concept of the urine test and specific reaction of the urine in various diseases according to Enrico Cauchi - member of the medical council of Malta (1933) 70
Sexual Dysfunction in Chronic Kidney Disease 69
Rene policistico autosomico dominante dell'adulto 69
Meccanismi di difesa in soggetti sottoposti a trattamento dialitico cronico 69
Extraskeletal Functions of Vitamin D 69
Antiosteoporotic activity of genistein aglycone in postmenopausal women: Evidence from a post-hoc analysis of a multicenter randomized controlled trial 69
Expert opinion of nephrologists about the effectiveness of low-protein diet in different stages of chronic kidney disease (CKD) 68
Vascular access for hemodialysis: current perspectives 68
[Periorbital purpura: a pathognomonic but late sign of AL amyloidosis] / Porpora periorbitaria: un segnale patognomonico ma tardivo di amiloidosi AL 68
Un caso di istiocitosi polmonare a cellule di Langerhans con sindrome nefrosica 67
Renoprotective effect of erythropoietin in zebrafish after administration of gentamicin: an immunohistochemical study for β-catenin and c-kit expression 67
Direct healthcare costs of chronic kidney disease management in Italy: What cost-savings can be achieved with higher biosimilar uptake and more appropriate use of erythropoiesis-stimulating agents? 67
Defense mechanisms in hemodialysis-dependent patients 66
Vitamin D receptor polymorphism in chronic kidney disease patients with complicated cardiovascular disease 66
Extracellular Matrix Abnormality May be resposible for Cyst Development 65
Ruolo dell’attività fisica nei riguardi dello stato nutrizionale e dellinsorgenza di diabete mellito de-novo in pazienti nefrotrapiantati 65
LA PLASMAFERESI IN NEFROLOGIA 65
Beneficial effects of oral pure caffeine on oxidative stress 65
Risk factors and action thresholds for the novel coronavirus pandemic. Insights from the Italian Society of Nephrology COVID-19 Survey 65
Autonomic dysfunction in uremia 64
R egistro siciliano trapianto renale :dati definitivi censimento 2000 64
il Registro regionale siciliano di dialisi e trapianto 1997-1998:dati preliminari 64
[Long-term outcome of renal function in women with preeclampia and pregestational diabetes] 64
eritropoeitina e funzione sessuale 63
Immunohistochemical Study of TGF-ß1 in Autosomal dominant Polycistic Kidney Disease (ADPKD). 63
Interplay of vitamin D, erythropoiesis, and the renin-angiotensin system 63
[Lupus Nephritis and Enteritis, a dual simultaneous involvement with Arteriolar Thrombosis] 63
Caso clinico di una bambina con lichen follicolare e sindrome nefrosica 62
Auxin induces cell proliferation in an experimental model of mammalian renal tubular epithelial cells 62
Endothelial dysfunction in chronic renal failure. 61
Nutritional status and de-novo diabetes in untrained renal transplant patients 61
TERAPIA DELLE GLOMERULONEFRITI A LESIONI ISTOLOGICHE MINIME 61
The Management of Diabetes Mellitus in Patients with Chronic Kidney Disease: A Population-Based Study in Southern Italy 61
Choice of dialysis treatment and type of medical unit (private vs public): application of a recursive bivariate probit 60
[From hyponatremia to tolvaptan] 60
Sevalamer Hydrochloride, Sevelamer Carbonate and Lanthanum Carbonate: In Vitro and In Vivo Effects on Gastric Environment 60
Contactin 1, a Potential New Antigen Target in Membranous Nephropathy: A Case Report 60
Behaviour of interleukin-18 in mesangial proliferative glomerulonephritis. 59
Impotence in the XVIII century as described by Gian Pietro Fusanacci and Tommaso Eduardo Beatty 59
Monoclonal antibodies for renal diseases: current concepts and ongoing treatments 59
Association of VDR gene polymorphisms with heart disease in chronic kidney disease patients 59
Kidney disease and psoriasis: novel evidences beyond old concepts 59
A new approach to the evaluation of hyperphosphatemia in chronic kidney disease 58
Acute renal failure secondary to retroperitoneal fibrosis as first manifestation of lupus nephritis 58
HLA haplotype in a patient with systemic lupus erythematosus triggered by hepatitis B vaccine 58
Medication is an additional source of phosphate intake in chronic kidney disease patients 58
Low birth weight is a conditioning factor for podocyte alteration and steroid dependance in children with nephrotic syndrome 58
Cardiorenal prognosis by residual proteinuria level in diabetic chronic kidney disease: pooled analysis of four cohort studies 58
Cross-sectional evaluation of kidney function in hospitalized patients: estimated GFR versus renal scintigraphy 58
Kidney-lung connections in acute and chronic diseases: current perspectives 58
Case report: Lichen Follicolare e Sindrome Nefrosica 57
Compliance ed emozioni in una popolazione di emodializzati 57
ACCIDENTAL DISCOVERY OF LUNG METATSTASES FROM DIFFERENTIATED THYROID CANCER BY TC-99M PERTECHNETATE SCAN IN A PATIENT WITH SECONDARY HYPERPARATHYROIDISM 57
ALTERAZIONI RENALI IN UN CASO DI CRIOGLOBULINEMIA MISTA DI TIPO 2 IN UN PAZIENTE AFFETTO DA LINFOMA CON CELLULE B. 56
Semaphorin 3A serum levels are influenced by haemodialysis: what clinical significance? 56
Discovery of new risk loci for IgA nephropathy implicates genes involved in immunity against intestinal pathogens 56
Circulating sclerostin and Dickkopf-1 correlate with vascular calcifications in non-dialysis chronic kidney disease 56
The Myth of Water and Salt: From Aquaretics to Tenapanor 56
Vitamin D status and the relationship with bone fragility fractures in HIV-infected patients: A case control study 56
Modificazione dei Componenti della Matrice Extracellulare nell'ADPKD. Studio immuno-istochimico al CLSM 55
Urine therapy through the centuries. 55
Thyroid hormone autoantibodies: Are they a better marker to detect early thyroid damage in patients with hematologic cancers receiving tyrosine kinase inhibitor or immunoregulatory drug treatments? 55
Negative Emotions in End-Stage Renal Disease: Are Anxiety Symptoms Related to Levels of Circulating Catecholamines? 55
Carnitine system in uremic patients: Molecular and clinical aspects 54
Phosphorus-related mechanisms of vascular calcification 54
Accidental discovery of lung metastases from differentiated thyroid cancer by 99mTc sodium pertechnetate scan in a patient with secondary hyperparathyroidism 54
ACUTE PARICALCITOL ADMINISTRATION REDUCE INFLAMMATION IN CKD PATIENTS IN VIVO AND IN VITRO 54
The Burden of Nephrotoxic Drug Prescriptions in Patients with Chronic Kidney Disease: A Retrospective Population-Based Study in Southern Italy 54
Procedimento e applicazione per la diagnosi predittiva di malattie rare 54
Evolution of the classification of acute and chronic transplant rejection 53
Salt-water imbalance and fluid overload in hemodialysis patients: a pivotal role of corin 53
Squilibri idrico-salini e sovraccarico di liquidi nei pazienti dializzati, il ruolo centrale di Corin 53
SCLEROSTIN AND DICKKOPF-1 CORRELATE WITH VASCULAR CALCIFICATIONS IN NON-DIALYSIS CHRONIC KIDNEY DISEASE 53
Totale 8.533
Categoria #
all - tutte 91.150
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 91.150


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.856 0 0 0 0 35 335 352 231 68 355 413 67
2020/20212.157 219 40 482 108 238 213 62 170 79 265 141 140
2021/20223.024 56 183 123 152 115 51 203 150 129 491 402 969
2022/20236.707 562 529 311 471 511 642 103 386 2.823 75 201 93
2023/20242.063 175 289 152 146 171 371 41 129 33 208 59 289
2024/20251.248 139 63 193 470 383 0 0 0 0 0 0 0
Totale 20.326